MedTrace Logo

Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness

NCT04905537 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2025-02-20

No results posted yet for this study

Summary

The researchers hope to establish an overall program of early genetic screening for neonatal critical illness in China, and to develop precise intervention strategies to assist clinical diagnosis and treatment of hereditary critical illness.

Conditions

  • Genetic Screening
  • Hereditary Disease
  • Newborn
  • Stillbirth

Interventions

OTHER

No intervention

It's only observational study. No interventions.

Sponsors & Collaborators

  • International Peace Maternity and Child Health Hospital

    collaborator OTHER

  • Obstetrics & Gynecology Hospital of Fudan University

    collaborator OTHER

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER

  • Shanghai Children's Medical Center

    collaborator OTHER

  • Shanghai Children's Hospital

    collaborator OTHER

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Wenhao Zhou · Children's Hospital of Fudan University

Eligibility

Max Age
100 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2025-11-30
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04905537 on ClinicalTrials.gov